Open AccessClinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study
Author(s) -
Shan Qiao,
Huai-Kuan Wu,
Lingling Liu,
Meiling Wang,
Ranran Zhang,
Tao Han,
Xuewu Liu
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s292343
Subject(s) - medicine , interquartile range , encephalitis , autoimmune encephalitis , immunotherapy , pediatrics , retrospective cohort study , glioma , immunology , cancer , cancer research , virus
To describe the clinical manifestation, immunotherapy, and long-term outcomes of anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.